Brought to you by:
Comparing office practice models: Should we joint venture?
In these challenging days of surviving private vascular practice, I’m sure we’re all considering our options. With rising overheads and reimbursement cuts, considering a joint venture can be an attractive option to share costs and expand growth potential. There are…
Speaking in code: How a decline in Medicare reimbursement affects vascular care
Concerns were raised yesterday’s Plenary Session 2 over the recent decline in Medicare reimbursement at a national level. Querying current figures, speakers revealed discrepancies which highlight the importance of accurate reporting to ensure sustainable provision for the future of vascular…
SVS calls for comments on Vascular Surgery MIPS Value Pathway
The Society for Vascular Surgery (SVS) announced that the Vascular Surgery MIPS Value Pathway (MVP) was posted for public comment by the Centers for Medicare & Medicaid Services (CMS). Developed by the SVS Quality and Performance Measure Committee (QPMC), the…
Why CMS should still not extend reimbursement indications for carotid stenting or other carotid ‘revascularization’ procedures
This commentary—authored by Anne Abbott, PhD, MBBS, Lawrence Schott, MD, Lan Gao, MMed, PhD, Hrvoje Budincevic, MD, PhD, Rishad Faruqi, MD, Tatjana Rundek, MD, PhD, Jean-Baptiste Ricco, MD, PhD, Saeid Shahidi, MD, and Gert J. de Borst, MD, PhD—consists of…
CMS: Proposed reduced conversion factor would cut vascular surgeon reimbursements
The Centers for Medicare & Medicaid Services (CMS) in mid-July released two payment-related proposed rules—the highly-anticipated calendar year (CY) 2024 Medicare Physician Fee Schedule Proposed Rule (MPFS) and the Medicare Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center…
The year in review: 2022 was an amazing 12 months for SVS
Despite any number of challenges, the Society for Vascular Surgery (SVS) had a hugely successful 2022 and looks forward to a bright 2023. Executive Director Kenneth M. Slaw, PhD, outlined a number of firsts for the Society, including: The year…
SVS looks to maintain AMA House of Delegates representation
To maintain its seat in the American Medical Association (AMA) House of Delegates—and, importantly, be able to provide information that impacts physician reimbursement—a 20% share of Society for Vascular Surgery (SVS) members must also maintain active membership at the AMA.…
Register today for two SVS courses
Registration has opened—along with early-bird pricing—for two Society for Vascular Surgery (SVS) in-person courses in coding and reimbursement, and peripheral artery disease (PAD) skills. Both will be held in October after being postponed in 2021 because of a surge in…
‘Disproportionate decrease’: Vascular surgeons see buying power fall, study finds
Inflation-adjusted Medicare reimbursement rates for the 20 most common vascular surgical procedures decreased by more than 20% in the last decade, a new analysis found. The study, which looked the buying power of vascular surgeons, uncovered data showing an unadjusted…
Medicare reimbursement fails to adequately cover cost of care after open bypass surgery among most CLTI patients
For most patients with chronic limb-threatening ischemia (CLTI), Medicare reimbursement for lower extremity bypass surgery does not adequately account for case complexity in the compensation of vascular surgeons, a study published in the September issue of the Journal of Vascular…